Krystal Biotech announced the full enrollment of a pivotal Phase 3 clinical trial of its topical gene therapy B-VEC (beremagene geperpavec) as a skin ...
https://www.google.com/url?rct=j&sa=t&url=https://epidermolysisbullosanews.com/2021/04/16/phase-3-trial-topical-gene-therapy-b-vec-deb-fully-enrolled/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNGngyP8ezBso-SOQFNbvOUQzWFV8A
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.